Photo Release -- Perseon Launches as a New Life Sciences Company in the Silicon Slopes of Utah
February 24 2015 - 9:15AM
BSD Medical Corporation (Nasdaq:BSDM) (the Company), a leading
provider of medical systems that utilize heat therapy to treat
cancer, today unveiled its new name and corporate identity, Perseon
Corporation (Perseon). The Company's new name is coupled with a new
visual identity, including the new tagline "Science for Humanity."
A photo accompanying this release is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=30942
"The change of our name to Perseon, a word with multiple
references to our mission and technology, succinctly represents our
focus as a pure play microwave ablation company with a market
leading product platform," said Clint Carnell, CEO of Perseon.
"Perseon is a truly authentic and memorable name that will resonate
with our customers and peers and clearly defines our purpose – to
ablate, or 'destroy,' diseased soft tissue (tumors). The
launch of our new name and identity is the first in a series of
rebranding initiatives that will support our goals in marketing and
education, peer-to-peer influence and clinical-based, product
innovation, all of which are essential to our future success in
life sciences. We are excited about our momentum and will be
sharing more about our new company in the weeks and months
ahead."
In conjunction with the corporate name change to Perseon, the
ticker symbol for BSD Medical's common shares traded on The Nasdaq
Capital Market will change from "BSDM" to "PRSN," effective
February 25, 2015.
Perseon's all-new corporate website at perseonmedical.com will
go live in the second quarter of 2015.
Perseon at SIR February 28 – March 5, 2015
Perseon will showcase its market-leading MicroThermX® microwave
ablation technology at the 40th Annual Scientific Meeting of the
Society of Interventional Radiology (SIR) being held February 28
through March 5, 2015 at Georgia World Congress Center in
Atlanta. Perseon will be located in Booth 551.
About Perseon
Perseon Corporation, formerly BSD Medical Corporation, is a life
sciences company that develops, manufactures, markets and services
groundbreaking medical systems to treat cancer using heat therapy.
Perseon's MicroThermX® microwave ablation system employs
precision-guided microwave energy to ablate diseased soft tissue.
The Company has developed extensive intellectual property and
distributes its products in the United States, Europe and Asia.
Forward-Looking Statements
Statements contained in this press release that are not
historical facts, including statements relating to our intent to
divest our hyperthermia business in Spring 2015, focus on microwave
ablation to create stockholder value, comply with Nasdaq continued
listing requirements, generate capital from a transaction related
to our building and pursue other strategic plans are
forward-looking statements, as defined in the Private Securities
Litigation Reform Act of 1995. All forward-looking statements are
subject to risks and uncertainties, including the risk that for a
variety of reasons we may not be able to execute on our strategic
plans, and other risks and uncertainties detailed in the Company's
filings with the Securities and Exchange Commission. These
forward-looking statements speak only as of the date on which such
statements are made, and the Company undertakes no obligation to
update such statements to reflect events or circumstances arising
after such date, except as required by law.
The photo is also available via AP PhotoExpress.
CONTACT: Tricia Ross
Financial Profiles
310-622-8226
tross@finprofiles.com